This is a regulatory disclosure filed with both the National Stock Exchange of India Ltd. and Bombay Stock Exchange Ltd. regarding an upcoming board meeting.
The Board of Directors meeting is scheduled for Wednesday, October 14, 2026. The primary agenda is to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended June 30, 2026 (Q2 FY27).
The disclosure also confirms that the trading window for dealing in the company's shares remains closed, continuing from the previous intimation dated September 28, 2026. The trading window closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and will remain effective until the announcement of Financial Results for the quarter ended September 30, 2026 (Q3 FY27).
The company will intimate the date of the subsequent Board Meeting for consideration and approval of unaudited financial results for the quarter and half year ended September 30, 2026 in due course.
The document is signed by Harish Sharma, Company Secretary & Compliance Officer (Membership No. A69173), and includes the company's CIN (U17299RJ2022PLC079631) and GSTIN (08ABHCS8575K1ZI).